Myasthenia gravis following IFN-alpha-2a treatment

dc.contributor.buuauthorBora, İbrahim
dc.contributor.buuauthorKarlı, Necdet
dc.contributor.buuauthorBakar, Mustafa
dc.contributor.buuauthorZarifoğlu, Mehmet
dc.contributor.buuauthorTuran, Faruk
dc.contributor.buuauthorOǧul, Erhan
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı.tr_TR
dc.contributor.scopusid6602914249tr_TR
dc.contributor.scopusid6506587942tr_TR
dc.contributor.scopusid26643051200tr_TR
dc.contributor.scopusid6603411305tr_TR
dc.contributor.scopusid17636734100tr_TR
dc.contributor.scopusid6603268541tr_TR
dc.date.accessioned2021-09-13T08:43:37Z
dc.date.available2021-09-13T08:43:37Z
dc.date.issued1997
dc.identifier.citationBora, İ. vd. (1997). "Myasthenia gravis following IFN-alpha-2a treatment". European Neurology, 38(1), 68-68.en_US
dc.identifier.endpage68tr_TR
dc.identifier.issn0014-3022
dc.identifier.issue1tr_TR
dc.identifier.pubmed9252802tr_TR
dc.identifier.scopus2-s2.0-0030786546tr_TR
dc.identifier.startpage68tr_TR
dc.identifier.urihttps://doi.org/10.1159/000112905
dc.identifier.urihttps://www.karger.com/Article/Abstract/112905
dc.identifier.urihttp://hdl.handle.net/11452/21882
dc.identifier.volume38tr_TR
dc.identifier.wosA1997XL25900012
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.journalEuropean Neurologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeurosciences & neurologyen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeKidney carcinomaen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMotor unit potentialen_US
dc.subject.emtreeMyasthenia gravisen_US
dc.subject.emtreeMyasthenia gravisen_US
dc.subject.emtreeNeutropeniaen_US
dc.subject.emtreePriority journalen_US
dc.subject.meshAutoimmunityen_US
dc.subject.meshHumansen_US
dc.subject.meshInterferon Alfa-2aen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshMyasthenia Gravisen_US
dc.subject.scopusMyasthenia Gravis; Vecuronium; Muscle Weaknessen_US
dc.subject.wosClinical neurologyen_US
dc.subject.wosNeurosciencesen_US
dc.titleMyasthenia gravis following IFN-alpha-2a treatmenten_US
dc.typeArticle
dc.wos.quartileQ3en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: